Protalix BioTherapeutics
PLX
#8125
Rank
A$0.32 B
Marketcap
$4.16
Share price
0.39%
Change (1 day)
120.27%
Change (1 year)

Protalix BioTherapeutics (PLX) - Net assets

Net assets on the balance sheet as of December 2024 : A$69.1 Million

According to Protalix BioTherapeutics 's latest financial reports the company has A$69.1 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Protalix BioTherapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$A$69.47 M41%
2023-12-31$A$49.27 M-415.13%
2022-12-31$-A$15.64 Million87.8%
2021-12-31$-A$8.33 Million-76.32%
2020-12-31$-A$35.17 Million-64.99%
2019-12-31$-A$0.11 Billion33.8%
2018-12-31$-A$75.07 Million98.94%
2017-12-31$-A$37.74 Million173.15%
2016-12-31$-A$13.82 Million-192.55%
2015-12-31$A$14.92 M-121.97%
2014-12-31$-A$67.94 Million124.89%
2013-12-31$-A$30.21 Million835.16%
2012-12-31$-A$3.24 Million-87.3%
2011-12-31$-A$25.44 Million128.15%
2010-12-31$-A$11.15 Million-163.05%
2009-12-31$A$17.68 M-71.87%
2008-12-31$A$62.85 M-13.71%
2007-12-31$A$72.84 M136.46%
2006-12-31$A$30.8 M269.82%
2005-12-31$A$8.32 M1202.24%
2004-12-31$A$0.63 M-27.46%
2003-12-31$A$0.88 M-37.6%
2002-12-31$A$1.41 M-23.76%
2001-12-31$A$1.85 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$0.31 B 349.06%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.14 B 5,893.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$141.52 B 204,702.02%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.14 B 13,137.37%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel